A Deadline is coming up on May 13, 2019in the lawsuit for certain investors in Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) shares and NASDAQ: CRBP stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 05/13/2019 -- The Shareholders Foundation announced that a deadline is coming up on May 13, 2019 in the lawsuit filed for certain investors of Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP).
Investors who purchased shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) have certain options and there are strict and short deadlines running. Deadline: May 13, 2019. NASDAQ: CRBP stockholders should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of purchasers of Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) common shares between November 14, 2016 and February 28, 2019, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between November 14, 2016 and February 28, 2019, the Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about its drug candidate Lenabasum.
Those who purchased shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels